Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPS24 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | TROVE2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
mRNA | RINL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | NDRG1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | TMEM262 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | SULF1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | MFSD13A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | FLRT2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | XPO7 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | C9orf24 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |